Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: Analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy

Oral Oncology

Volumn 48, Issue 8, 2012, Pages 723-729

  Urba, Susan ^a   Gatz, Jennifer ^b   Shen, Wei ^b   Hossain, Anwar ^b   Winfree, Katherine ^b   Koustenis, Andrew ^b   Peterson, Patrick ^b   Cohen, Ezra E W ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cisplatin; Pemetrexed; Prognostic factors; Quality of life; Recurrent and metastatic head and neck cancer

Indexed keywords

CISPLATIN; PEMETREXED;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; EMOTION; FAMILY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SOCIAL ASPECT; WELLBEING;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FEMALE; GLUTAMATES; GUANINE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84864409760     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.02.016     Document Type: Article

References (22)

1. R.I. Haddad, and D.M. Shin Recent advances in head and neck cancer New Engl J Med 359 11 2008 1143 1154
2. A.D. Colevas Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck J Clin Oncol 24 17 2006 2644 2652 (Pubitemid 46628471)
3. C. Quinten, C. Coens, M. Mauer, S. Comte, M.A. Sprangers, and C. Cleeland EORTC Clinical Groups. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from ETORT clinical trials Lancet Oncol 10 9 2009 865 871
4. J. Dancey, B. Zee, D. Osoba, M. Whitehead, F. Lu, and L. Kaizer Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group Qual Life Res 6 2 1997 151 158 (Pubitemid 27207280)
5. Y. Qi, S.E. Schild, S.J. Mandrekar, A.D. Tan, J.E. Krook, and K.M. Rowland Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer J Thorac Oncol 4 9 2009 1075 1082
6. I. Chau, A.R. Norman, D. Cunningham, J.S. Waters, J. Oates, and P.J. Ross Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer - pooled analysis from three multicenter, randomized, controlled trials using individual patient data J Clin Oncol 22 12 2004 2395 2403 (Pubitemid 41121931)
7. M.M. Huschka, S.J. Mandrekar, P.L. Schaefer, J.R. Jett, and J.A. Sloan A pooled analysis of quality of life measures and adverse events data in North Central Cancer Treatment Group Lung Cancer Clinical Trials Cancer 109 4 2007 787 795 (Pubitemid 46233242)
8. L. Collette, G. van Andel, A. Bottomley, G.O. Oosterhof, W. Albrecht, and T.M. de Reijke Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organization for Research and Treatment of Cancer Genito-urinary Group J Clin Oncol 22 19 2004 3877 3885 (Pubitemid 41079868)
9. C.C. Gotay, T. Kawamoto, A. Bottomley, and F. Efficace The prognostic significance of patient-reported outcomes in cancer clinical trials J Clin Oncol 26 8 2008 1355 1363
10. C.A. Karvonen-Gutierrez, D.L. Ronis, K.E. Fowler, J.E. Terrell, S.B. Gruber, and S.A. Duffy Quality of life scores predict survival among patients with head and neck cancer J Clin Oncol 26 16 2008 2754 2760
11. A. Montazeri Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008 Health Qual Life Outcomes 7 2009 102
12. H.M. Mehanna, and R.P. Morton Patients' views on the utility of quality of life questionnaires in head and neck cancer: a randomised trial Clin Otolaryngol 31 4 2006 310 316 (Pubitemid 44141097)
13. Urba S, van Herpen CML, Sahoo TP, Shin DM, Licitra L, Mezei K, et al. Phase III study of pemetrexed in combination with cisplatin (PEM/CIS) versus placebo plus cisplatin (CIS) in patients with recurrent or metastatic squamous cell head and neck cancer (HNC). Ann Oncol 2010;21(suppl 8):1003O [abstract].
14. M.A. List, L.L. D'Antonio, D.F. Cella, A. Siston, P. Mumby, and D. Haraf The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity Cancer 77 11 1996 2294 2301 (Pubitemid 26162422)
15. J.S. Temel, J.A. Greer, A. Muzikansky, E.R. Gallagher, S. Admane, and V.A. Jackson Early palliative care for patients with metastatic non-small-cell lung cancer N Engl J Med 363 8 2010 733 742
16. D.P. Goldstein, L. Hynds Karnell, A.J. Christensen, and G.F. Funk Health-related quality of life profiles based on survivorship status for head and neck cancer patients Head Neck 29 3 2007 221 229 (Pubitemid 46339318)
17. L.M. Grignon, M.J. Jameson, L.H. Karnell, A.J. Christensen, and G.F. Funk General health measures and long-term survival in patients with head and neck cancer Arch Otolaryngol Head Neck Surg 133 5 2007 471 476 (Pubitemid 46799783)
18. F. Efficace, A. Bottomley, C. Coens, K. Van Steen, T. Conroy, and P. Schöffski Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 42 1 2006 42 49 (Pubitemid 41814531)
19. P.A. Ganz, C.A. Schag, and H.L. Cheng Assessing the quality of life - a study in newly-diagnosed breast cancer patients J Clin Epidemiol 43 1 1990 75 86 (Pubitemid 20036969)
20. K.B. Wells, A. Stewart, R.D. Hays, M.A. Burnam, W. Rogers, and M. Daniels The functioning and well-being of depressed patients. Results from the Medical Outcomes Study JAMA 262 7 1989 914 919 (Pubitemid 19208948)
21. E.M. Reiche, S.O. Nunes, and H.K. Morimoto Stress, depression, the immune system, and cancer Lancet Oncol 5 10 2004 617 625 (Pubitemid 39303129)
22. J.H. Seok, L.S. Kim, N. Hong, H.J. Hong, S.J. Kim, and H.J. Kang Psychological and neuroendocrinological characteristics associated with depressive symptoms in breast cancer patients at the initial cancer diagnosis Gen Hosp Psychiatry 32 5 2010 503 508